Clinical trialNCT06181227TerminatedPhase 2Interventional

A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema

SponsorAviceda Therapeutics, Inc.Enrollment21Diabetic Macular EdemaDiabetic Retinopathy

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A Phase 2 study to determine the safety and preliminary efficacy of intravitreal injections of AVD-104, a novel glyco-mimetic nanoparticle, in reducing macular edema associated with diabetic retinopathy.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

David Callanan, MD
Aviceda Therapeutics
Study DirectorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Erie Retina Research
Erie, Pennsylvania, United States
Texas Retina Associates
Dallas, Texas, United States
West Texas Retina Consultants
Wichita Falls, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AVD-104

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Nov 2023
Primary completion: 5 Apr 2024
Completion: 5 Apr 2024
Last update posted: 14 Jul 2025
Registered enrollment: 21
Registry id: NCT06181227

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.